Skip to main content
AVA 2025 Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Separate Fee
Requires Separate Fee
Peds/Neo SIG
Peds/Neo SIG
Patient Track
Patient Track
International Speakers
International Speakers
Scientific Poster Presentations
Scientific Poster Presentations
ACCME Credit
ACCME Credit
CRNI Credit
CRNI Credit
On-Demand
On-Demand
Coffee Break
Coffee Break
Reception
Reception
Meal
Meal
Evaluation On-Demand Video ViewAttendees 32

Abstract Submission

Science

(I3) Seeing is Believing: The Evolution, Importance, and Future of Vein Visualization Technology

Sunday, September 21, 2025
7:30 AM - 8:45 AM ET
Location: Suwannee 3-4
Earn 1 CE Hour(s)
International Speakers On-Demand
Disclosure(s):
Peter J. Carr, PhD MMedSc BSc: VeinTech: Consultant (Ongoing), Receive Share options as a Clinical and Scientific Advisory Board Chair of VeinTech (Ongoing)
Matthew D. Ostroff, MSN, AGACNP, VABC: No financial relationships to disclose
This session will explore the evolution of vein visualization technology used to assist in peripheral intravenous cannulation. It will cover the range of tools available to clinicians today, from traditional to advanced options like ultrasound and infrared imaging. We will synthesize evidence on the effectiveness of these technologies and examine challenges related to patient outcomes, clinical adoptability, patient satisfaction, and healthcare costs. Attendees will gain insight into the current limitations of vein visualization tools and an understanding of emerging technologies that aim to bridge existing gaps, such as AI-enhanced imaging and portable devices. This session combines analysis and interactive discussion to promote a deeper understanding of vein visualization’s impact on patient care.

Learning Objectives:

  • By the end of this session the participant will be able to understand the origin of vein visualisation, issues with current technologies, and what is to come in the future.
  • By the end of this session the participant will be able to understand what evidence supports these technologies.
  • By the end of this session the participant will be able to understand that next generation technologies are needed and what are currently emerging.
  • By the end of this session the participant will understand why novel ultrasound vein visualisation technology need validated processes before procurement and clinical adoptability prior to prospective evaluation for effectiveness.